Conférences - Législation en médecine et pharmacologie

Sélecionner un pays
TOUS LES PAYS (7)
1
India Health Exhibition & Conferences
14 avr 2020 - 16 avr 2020 • Delhi, Inde
Organisateur:
Informa Markets
Résumé:
Healthcare has become one of India’s largest sectors both in terms of revenue and employment. India Health presents an opportunity to all stakeholders in search of a platform that facilitates business interaction, learning and development, and access to the right healthcare entities, authorities and associations in a fast-emerging economy.
Contact:
Tél.: [+971 4 407 2655];     Email.: nikita.arora@informa.com
Sujets:
Medicine, Healthcare
Identifiant de l'évènement:
1292576
Sujets apparentés:
2
5th Annual ComplianceOnline Medical Device Summit 2020
16 avr 2020 - 17 avr 2020 • Boston, États-Unis
Organisateur:
ComplianceOnline
Résumé:
Innovate novel ideas for advancements in medical device technologies without compromising their safety and effectiveness. This summit brings together some of the renowned R&D experts and technology innovators to share information regarding opportunities, obstacles, best practices and challenges in the development of the new devices. Attendees will get insight into device innovation trends and upcoming changes in the medical device regulations.
Contact:
Tél.: [18887172436];     Email.: referral@complianceonline.com
Identifiant de l'évènement:
1307083
Sujets apparentés:
3
The Risk-Based Approach to Pharmacovigilance Audits - A Practical Approach to Design and Implementation
20 avr 2020 - 21 avr 2020 • San Francisco, CA, États-Unis
Organisateur:
Complianceonline
Résumé:
European Medicines Agency's (EMA) Guideline on good pharmacovigilance practices (GVP), Module IV requires that risk-based audits of the quality system be performed at regular intervals to assure that it complies with the established quality requirements and to determine its effectiveness. It includes audit of the pharmacovigilance system which is covered by the quality system. The GVP Modules are applicable to EU-based companies and any company marketing medicinal products on a global basis. The legally required risk-based audit strategy has to cover all PV processes and tasks undertaken by or delegated to other departments, Marketing Authorization Holder affiliates, and third parties such as distributors, external service providers, licensing partners. In other words, has to cover all PV Universe. The PV Audit Strategy Plan is used to prepare the PV audit program, i.e. annual PV Audit Schedule. Using risk-based approach to develop an audit strategy, companies can conform to the regulatory requirements and business needs. But the questions remain: How to do it? Where to start? How to improve? What are the best industry practices?
Contact:
Tél.: [18887172436];     Email.: referral@complianceonline.com
Sujets:
PV Audit Strategy Planning, The European Medicines Agency's (EMA) Guideline, Good Pharmacovigilance Practices (GVP), risk-based audits, GVP Modules, PV Universe, PV Audit Strategy Plan, PV processes and activities, Safety data exchange agreements (SDEAs), vendor contracts, SOPs, Procedure Documents
Identifiant de l'évènement:
1329202
4
FDDUK 2020 — 6th Annual Formulation & Drug Delivery Congress
22 avr 2020 - 23 avr 2020 • Londres, Royaume-Uni
Organisateur:
Oxford Global
Contact:
Tél.: [+441865248455];     Email.: e.hawkings@oxfordglobal.co.uk
Sujets:
Pharmaceutical, Drug Development, Formulation, Drug Delivery
Identifiant de l'évènement:
1296190
5
Designing and Sustaining New and Existing Product Stability Testing Program
23 avr 2020 - 24 avr 2020 • Tampa, FL, États-Unis
Organisateur:
Complianceonline
Résumé:
This seminar will provide a great resource to Pharmaceutical, Biotechnology, Diagnostics, Cell Therapy, Drugs, Biologics, OTC, Radio-pharmaceutical, Pharmacies and Medical Device Industries in understanding the effective way to establish a new or modified product stability testing program. This program is an important part of a product's regulatory filing requirements as well as the determination of the shelf life or expiration date of the product. This is an important part of every business final bottom line or indirectly relationship to their supply and warehouse chain (how long the product can be stored before it can be discarded). Understanding how to design and implement an effective stability testing program following the regulatory guidelines will allow the product to be manufactured, tested, released, adequately stored and effectively tested for stability and ultimately used through its actual end point based on the product's potency. This will eliminate potential loss of product and business income by manufacturers of product (i.e. when a potent product is inadvertently discarded due to a poorly designed stability testing program) which ends up impacting the products' regulatory filing status or a product's Regulatory Filing/Application. The focus of this seminar will create a detailed process that will guide the attendees in the right direction in the planning of a new or existing product's stability testing plan, program, protocol, handing and utilizing the data, setting the shelf life as well as the applicable regulatory requirements.
Contact:
Tél.: [18887172436];     Email.: referral@complianceonline.com
Identifiant de l'évènement:
1334463
6
LESI 2020 Conference
16 mai 2020 - 20 mai 2020 • Berlin, Allemagne
Contact:
Email.: conferencemarketing@conventus.de
Sujets:
licensing community
Identifiant de l'évènement:
1307009
7
2nd Drug Delivery Conference
20 jul 2020 - 23 jul 2020 • Lisbonne, Portugal
Résumé:
This conference focuses on the design, synthesis and clinical validation of new drug delivery vehicles. This conference is designed to bridge the gap between basic science and unmet clinical needs.
Contact:
Conference Manager;     Tél.: [00441638724137];     Email.: admin@fusion-conferences.com
Sujets:
Therapeutic gene editing, Extrahepatic delivery of nucleic acids, Characterization of therapeutic nanoparticles and control strategies for manufacturing, New linkers for triggered or controlled release, New long acting technologies, Tumor targeting with nanoparticles, recent progress and challenges
Identifiant de l'évènement:
1279392


Conference-Service.com met à la disposition de ses visiteurs des listes de conférences et réunions dans le domaine scientifique. Ces listes sont publiées pour le bénéfice des personnes qui cherchent une conférence, mais aussi, bien sûr, pour celui des organisateurs. Noter que, malgré tout le soin que nous apportons à la vérification des données entrées dans nos listes, nous ne pouvons accepter de responsabilité en ce qui concerne leur exactitude ou étendue. Pensez donc à vérifier les informations présentées avec les organisateurs de la conférence ou de la réunion avant de vous engager à y participer!

Dernière mise à jour: 21 Février 2020